Andre M. Kallab

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Sandra M. Swain, David Miles, Sung‐Bae Kim et al. · The Lancet Oncology · 2020 · 854 citations

End-of-study Results, Breast Oncology, Medicine +8

Mifepristone Induces Growth Arrest, Caspase Activation, and Apoptosis of Estrogen Receptor-Expressing, Antiestrogen-Resistant Breast Cancer Cells

Virgil T. Gaddy, John T. Barrett, Jennifer N. Delk et al. · Clinical Cancer Research · 2004 · 69 citations

Treatment of a patient with end‐stage renal disease with Rituximab: Pharmacokinetic evaluation suggests Rituximab is not eliminated by hemodialysis

Anand P. Jillella, Paul Dainer, Andre M. Kallab et al. · American Journal of Hematology · 2002 · 65 citations · Full text

Anal melanoma: an aggressive malignancy masquerading as hemorrhoids.

Michael W. Felz, Ginger B. Winburn, Andre M. Kallab et al. · PubMed · 2001 · 52 citations

Physician Recognition, Surgical Oncology, Tumoral Pathology +12

Induction of antiproliferation and apoptosis in estrogen receptor negative MDA-231 human breast cancer cells by mifepristone and 4-hydroxytamoxifen combination therapy: A role for TGFβ1

Yayun Liang, Min Hou, Andre M. Kallab et al. · International Journal of Oncology · 2003 · 38 citations

Breast Oncology, Oncology, 4-Hydroxytamoxifen Combination Therapy +14